share

4-(2,2-Dimethyl-3-Oxo-Octahydro-Quinoxalin-1-Yl)-4-Oxo-Butyric Acid CAS NO 801228-30-8


Unit Price:

CAS No.:801228-30-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

4-(2,2-Dimethyl-3-Oxo-Octahydro-Quinoxalin-1-Yl)-4-Oxo-Butyric Acid is a high-purity, specialized organic compound featuring a complex quinoxaline-derived structure. This chemical is valued for its role as a critical advanced pharmaceutical intermediate in the synthesis of novel active ingredients. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly within medicinal chemistry and process R&D.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of complex drug candidates, particularly those targeting neurological or metabolic pathways.
  • Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies for novel therapeutic compounds.
  • Process Chemistry Development: Serves as a starting material or intermediate in scaling up synthetic routes for Active Pharmaceutical Ingredients (APIs).
  • Bioconjugation & Probe Synthesis: Potential use in creating labeled compounds or molecular probes for biochemical and diagnostic research due to its functionalized structure.
  • Academic & Industrial R&D: Employed in universities and corporate labs for exploratory synthesis and the development of new chemical entities.

Basic Information

Product Name 4-(2,2-Dimethyl-3-Oxo-Octahydro-Quinoxalin-1-Yl)-4-Oxo-Butyric Acid
CAS No. 801228-30-8
Molecular Formula C₁₆H₂₄N₂O₄
Molecular Weight 308.37 g/mol
Synonyms 4-(2,2-Dimethyl-3-oxo-1,2,3,4,5,6,7,8-octahydroquinoxalin-1-yl)-4-oxobutanoic acid; 4-(2,2-Dimethyl-3-oxooctahydroquinoxalin-1-yl)-4-oxobutanoic Acid; 801228-30-8; Butanoic acid, 4-(2,2-dimethyl-3-oxo-1,2,3,4,5,6,7,8-octahydro-1-quinoxalinyl)-4-oxo-; 4-(2,2-Dimethyl-3-oxo-1,2,3,4,5,6,7,8-octahydroquinoxalin-1-yl)-4-oxobutyric acid
EINECS Contact for details

Quality Control

Our 4-(2,2-Dimethyl-3-Oxo-Octahydro-Quinoxalin-1-Yl)-4-Oxo-Butyric Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure high purity and consistency, meeting the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic and spectroscopic data are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference
Assay (HPLC) ≥ 97.0%
Related Substances (HPLC) Total impurities ≤ 3.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.